Skip to content Skip to footer
Menu Close
Close

Women’s Health

Uterine Fibroid Research Study Evaluating Investigational Therapy for Safety and Contraceptive Effectiveness

Uterine Fibroids Study

Uterine Fibroids Clinical Trials in Los Angeles

Uterine fibroids and endometriosis are common gynecologic conditions that can cause symptoms such as pelvic pain, heavy menstrual bleeding, and discomfort that may affect daily life. Continued research is important to better understand treatment options and support women’s reproductive health needs.

Zillan Clinical Research is conducting a Phase III study evaluating an investigational once-daily oral combination therapy in women with uterine fibroids or endometriosis. The study is designed to assess the safety of the treatment and its effectiveness in preventing pregnancy when used as the sole method of contraception, while participants receive ongoing clinical monitoring and study-related care.

See Eligibility Criteria
About This Study

Evaluating Safety and Contraceptive Effectiveness in Women with Uterine Fibroids or Endometriosis

Many women with fibroids or endometriosis continue to experience pain, heavy periods, and fatigue that interfere with daily life, even after trying available treatment options. When symptoms persist, it can significantly affect overall wellbeing and quality of life.

This Phase III uterine fibroid research study is evaluating a an investigational once-daily oral combination therapy in women with uterine fibroids or endometriosis who are at risk of pregnancy. The study evaluates whether the treatment can prevent pregnancy when used as the only method of contraception over 13 treatment cycles, along with safety monitoring. Participants receive study-related care and close clinical monitoring at no cost.

Now Enrolling

Current Status

Uterine Fibroids or Endometriosis

Condition
Partner With Us
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we conduct ethical, high-quality clinical studies focused on patient safety, scientific integrity, and advancing innovative treatments for better health outcomes.

Integrity

Conducting all studies with honesty, transparency, and strict ethical standards

Patient Safety

Prioritizing participant well-being through close monitoring and care

Scientific Excellence

Following high-quality research practices and global clinical standards

Innovation

Supporting advanced research approaches that drive medical progress

Diversity & Inclusion

Ensuring studies reflect real-world patient populations

Trusted Oversight

Operating under regulated, GCP-compliant clinical research processes

FAQ

Frequently Asked Questions

It is a Phase III clinical trial evaluating a an investigational once-daily oral combination therapy in women with uterine fibroids or endometriosis who are at risk of pregnancy. The study is designed to assess the treatment's contraceptive effectiveness and safety.

Premenopausal women diagnosed with uterine fibroids or endometriosis who meet the study's eligibility requirements and are at risk of pregnancy may be considered for participation following a full clinical screening.

Yes. Uterine fibroid clinical trials are currently being conducted at clinical research sites in Los Angeles, CA to evaluate investigational treatment options for women with uterine fibroids or endometriosis.

Participants receive the investigational treatment and attend scheduled clinic visits for health evaluations, pregnancy testing, safety assessments, and ongoing monitoring by the study team.

Yes. Eligible participants may receive study-related visits, assessments, study medication, and monitoring at no cost throughout their participation in the study.

Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today